WHITNEY COFFEY: Open Payments
NPI 1629605407 · WINFIELD, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,878 in 87 payments from 26 companies in 2025. Trend: 2023 $1,326 · 2024 $2,096 · 2025 $1,878
Food & beverage: $1,699Education: $179
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $207 |
| Novartis Pharmaceuticals Corporation | 8 | $188 |
| SEAGEN INC. | 2 | $179 |
| PFIZER INC. | 9 | $176 |
| E.R. Squibb & Sons, L.L.C. | 9 | $166 |
| Celgene Corporation | 9 | $161 |
| ARRAY BIOPHARMA INC | 4 | $113 |
| Merck Sharp & Dohme LLC | 5 | $101 |
| Daiichi Sankyo Inc. | 5 | $100 |
| Janssen Biotech, Inc. | 5 | $94 |
Products named: IMFINZI, OPDIVO, REBLOZYL, BRAFTOVI, KEYTRUDA, Enhertu, KISQALI, XTANDI.
Industry payments across AL — which companies pay providers there.
